Product search
Sort by
Search results
ZYMUTEST HIA, IgG, IgA, IgM
Complete isotyping of heparin dependent antibodies, as a primary approach in research applications or as a second intention assay for characterizing patients measured positive with the ZYMUTEST HIA IgGAM, screening assay (# RK040D).
ZYMUTEST HIA, IgA
Measurement of human heparin-dependent antibodies of the IgA isotype, in research or prospective studies on development of HIT during heparin therapy.
ZYMUTEST HIA, IgM,
Measurement of human heparin-dependent antibodies of the IgM isotype, in research or prospective studies on the risk of HIT development during heparin therapy.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.